MOHW mulls NHI drug approval. system based on positive list

Published: 2004-03-15 06:58:00

Updated: 2004-03-15 06:58:00

MOHW said that almost all of drugs registered to KFDA were automatically listed to the NHI reimbursement book, for which, MOHW thought it to raise problems that should be trimmed in view of efficient NHI drug controls, and therefore announced "Assigned study projects for health medical technology research and development in 2004" covering all future innovation programs including the above said ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.